AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other biopharma firms. Aside from JPM conference coverage, our reporters are making their way around town for one-on ...

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Season 13 of My 600-lb Life premiered Jonathan's Journey, on Wednesday, January 1, 2025. It showcased Jonathan grappling with the challenges of weighing over 600 pounds. Unhappy with his body's ...

The premiere of My 600-lb Life season 13, titled Jonathan’s Journey, aired on January 1, 2025. The episode followed Jonathan Colp, a 36-year-old from Macedonia, Illinois, who weighed 641 pounds ...

She’s bringing in the New Year with a bang — or a thousand. After bedding more than 600 people in 2024, ambitious Annie Knight is vowing to up the ante from Jan. 1. The bawdy blonde ...

AbbVie (ABBV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...